The present literature further suggests that CHRNA5 may act as an oncogene possibly through its potential role in DNA damage response (DDR) as well as alteration of known cancer signaling pathways such as JAK/STAT, PI3K/AKT and Ras/Raf/MEK/ERK [13]. The gene discussed is CHRNA5; the disease is cancer.